LJI and Synbal, Inc. partner to develop better COVID-19 models
New mouse models may shed light on the puzzling aspects of SARS-CoV-2 infection
New mouse models may shed light on the puzzling aspects of SARS-CoV-2 infection
New LJI review shows how T cells target more than 1,400 sites on SARS-CoV-2
LJI scientists uncover coordinated immune cell activity as a driver of systemic lupus erythematosus
New study highlights VP40 as a promising therapeutic target
New LJI research could guide the development of more effective cancer immunotherapies
LA JOLLA—A team of scientists at La Jolla Institute for Immunology (LJI) has won the XPRIZE Rapid COVID Testing competition.
Phase 2 trial run by Novo Nordisk emphasizes the importance of translational research
As she advances global health, LJI Professor Sujan Shresta takes on three new research projects to support equity for scientists in South and Southeast Asia
In addition to developing the antibodies for use in diagnostic applications based on N protein-specific antibodies, Leinco will make these antibodies commercially available as part of their extensive catalogue of research tools.
New LJI research gives detailed look at vulnerable sites on the novel coronavirus—beyond the receptor binding domain
New fellowship will support data science and immunology cross-training in two pioneering LJI labs
New research highlights the enormous variability in how T cells respond to the deadly virus